These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22665482)

  • 1. Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.
    Mukherjee A; Wu J; Barbour S; Fang X
    J Biol Chem; 2012 Jul; 287(30):24990-5000. PubMed ID: 22665482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.
    Ha JH; Ward JD; Varadarajalu L; Kim SG; Dhanasekaran DN
    Cell Signal; 2014 Jan; 26(1):122-32. PubMed ID: 24055910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.
    Ray U; Roy SS
    FEBS J; 2018 Feb; 285(3):432-443. PubMed ID: 28971574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12.
    Radhika V; Hee Ha J; Jayaraman M; Tsim ST; Dhanasekaran N
    Oncogene; 2005 Jun; 24(28):4597-603. PubMed ID: 15856019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer.
    Wang W; Wu J; Mukherjee A; He T; Wang XY; Ma Y; Fang X
    FASEB J; 2020 Oct; 34(10):13935-13948. PubMed ID: 32851734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
    Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
    Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
    Lee CW; Rivera R; Dubin AE; Chun J
    J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells.
    Mukherjee A; Ma Y; Yuan F; Gong Y; Fang Z; Mohamed EM; Berrios E; Shao H; Fang X
    Neoplasia; 2015 Sep; 17(9):723-734. PubMed ID: 26476080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells.
    Saunders JA; Rogers LC; Klomsiri C; Poole LB; Daniel LW
    Free Radic Biol Med; 2010 Dec; 49(12):2058-67. PubMed ID: 20934509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
    Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
    Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
    Hu YL; Albanese C; Pestell RG; Jaffe RB
    J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic Acid Induces Aerobic Glycolysis, Lipogenesis, and Increased Amino Acid Uptake in BV-2 Microglia.
    Joshi L; Plastira I; Bernhart E; Reicher H; Koyani CN; Madl T; Madreiter-Sokolowski C; Koshenov Z; Graier WF; Hallström S; Sattler W
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells.
    Jeon ES; Heo SC; Lee IH; Choi YJ; Park JH; Choi KU; Park DY; Suh DS; Yoon MS; Kim JH
    Exp Mol Med; 2010 Apr; 42(4):280-93. PubMed ID: 20177148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
    Fan Q; Cai Q; Xu Y
    Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.
    Zhao P; Yun Q; Li A; Li R; Yan Y; Wang Y; Sun H; Damirin A
    Med Oncol; 2022 Jan; 39(2):17. PubMed ID: 34982278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
    Li H; Ye X; Mahanivong C; Bian D; Chun J; Huang S
    J Biol Chem; 2005 Mar; 280(11):10564-71. PubMed ID: 15653692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
    Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
    Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
    Hurst JH; Henkel PA; Brown AL; Hooks SB
    Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.